NEW YORK, Nov. 15, 2016 /PRNewswire/ -- Western blotting technique or protein immunoblot is used for detection and quantification of specific protein molecules in the given complex protein sample. A protein molecule is separated on the basis of molecular weight and size, forming bands on the gel, which is further transferred onto the transfer membrane for visualization and analysis of western blot. Western blotting market contributes the major share to the molecular diagnostics market in terms of revenue. Molecular diagnostics include various analytical techniques used in the field of proteomics and genomics. Western blotting technique is considered as the gold standard for the diagnosis of HIV. Western blotting, due to its high specificity and reproducibility, is used as a confirmatory test for the diagnosis of HIV.
According to the World Health Organization (WHO), it is estimated that in 2013, only 51% of the people with HIV knew about their syndrome status. The major reason for low diagnosis of HIV is attributed to fear of being positively diagnosed with HIV and confidentiality issues related to testing results. As per the statistics released by the joint United Nations program on HIV/AIDS, in 2013, around 35.2 Mn HIV cases were recorded with two million new cases being detected in 2014, taking the combined total for both years to 37.2 Mn. Wide application of western blotting technique in various fields such as scientific research, medical diagnostics, food & beverages industry, agricultural, and other applications is fueling the growth of the western blotting market globally.
The western blotting market is segmented as follows:
Western blotting, by product
Western blotting, by application
Western blotting, by end use
Western blotting, by region
This report covers the global western blotting market performance in terms of revenue contribution. This section also includes PMR analysis of key trends, drivers, restraints, and opportunities that are influencing the global western blotting market. Impact analysis of key growth drivers and restraints are included in this report to better equip clients with crystal clear decision-making insights. The report also offers global company share analysis for the year 2014.
By product, the global western blotting market is segmented into electrophoresis blotting systems, reagent kits, and transfer membrane. Of these, reagent kits segment accounts for majority market share currently and is expected to remain the leading segment in terms of volume and value during the forecast period. Transfer membranes segment is expected to expand in terms of value and volume, but at a relatively slower pace as compared to other segments. Electrophoresis blotting systems segment is expected to register higher CAGR in terms of value and volume over the forecast period as compared to other segments.
By end user, the global western blotting market is segmented into diagnostics laboratories, research institutes, and pharmaceuticals and biotechnology companies. Pharmaceuticals and biotechnology companies segment dominated the western blotting market in 2014 as compared to other segments. However, research institutions segment is projected to register a higher CAGR over the forecast period as compared to other segments mainly due to continuous research work in the field of proteomics. Diagnostics laboratories segment accounted for least share in the global western blotting market in terms of revenue and volume in 2014, and the trend is expected to continue till 2021. Usage of western blotting technique is expected to expand in the diagnostics laboratories and research institutions segments by the end of 2021.
By region, North America is expected to remain the market leader in the western blotting market, mainly due to the availability of sufficient funds to pursue research work in the field of proteomics, increasing investment in R&D initiatives by various pharmaceuticals and biotechnology companies. Revenue from the market in APAC is projected to increase at a significant pace, mainly due to large population base and increasing awareness amongst physicians regarding the need for early detection of HIV. The market in Latin America and North America are expected to follow APAC in terms of value during the forecast period. MEA market is relatively untapped, hence representing the vast potential for various companies in this region. The high price of products and availability of advanced technology is an issue in certain regions.
Key market players covered in this report include Thermo Fisher Scientific, Inc., GE Healthcare, Hoffmann-La Roche Ltd., Danaher Corporation (Lumigen, Inc.), EMD Millipore Corporation, Bio-Rad Laboratories, Inc., PerkinElmer Inc., LI-COR, Inc., Bio-Techne Corporation (ProteinSimple Inc.), and Advansta, Inc. These players have been profiled on the basis of various attributes such as company overview, recent developments, growth strategies, sustainability, and financial overview.
Read the full report: http://www.reportlinker.com/p04040038-summary/view-report.html
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
Intl: +1 339-368-6001